Breaking News Instant updates and real-time market news.

CERN

Cerner

$58.86

1.35 (2.35%)

, CPSI

Computer Programs

$27.80

0.455 (1.66%)

04:55
02/13/19
02/13
04:55
02/13/19
04:55

William Blair to hold company meetings at a conference

William Blair Company Meetings & Booth Tours at HIMSS 2019 will be held in Orlando, FL on February 12-13.

CERN

Cerner

$58.86

1.35 (2.35%)

CPSI

Computer Programs

$27.80

0.455 (1.66%)

MDRX

Allscripts

$12.00

0.3 (2.56%)

PINC

Premier

$37.10

0.55 (1.50%)

VCRA

Vocera

$30.90

0.9 (3.00%)

  • 13

    Feb

  • 15

    Feb

  • 21

    Feb

CERN Cerner
$58.86

1.35 (2.35%)

02/07/19
SBSH
02/07/19
NO CHANGE
SBSH
Buy
Citi opens 'Positive Catalyst Watch' on Cerner into investor day
Citi analyst Stephanie Demko opened a "Positive Catalyst Watch" on Cerner ahead of the company's investor community meeting next Wednesday, February 13. The analyst believes the main focus will be a "more achievable" mid-term guidance and broadening uses of cash. Both of these should be well received by investors, Demko tells investors in a research note. The analyst likes Cerner's risk/reward going into the investor day and keeps a Buy rating on the shares.
11/29/18
PIPR
11/29/18
NO CHANGE
Target $70
PIPR
Cerner sees VA contract accretive to profitability, says Piper Jaffray
Cerner CFO Marc Naughton provided details today on the company's Veterans Affairs award, Piper Jaffray analyst Sean Wieland tells investors in a research note from his firm's annual conference. The company expects the contract to be accretive to profitability and for each launch to get easier as it builds expertise, adds the analyst. He keeps an Overweight rating on Cerner with a $70 price target.
01/08/19
PIPR
01/08/19
NO CHANGE
PIPR
Overweight
Piper survey finds 'remarkable increase' in receptivity to telemedicine
Piper Jaffray analyst Sean Wieland says his firm's third annual consumer healthcare survey reveals a "remarkable increase" in consumer receptivity to telemedicine. The likelihood of someone choosing telemedicine has doubled year-over-year to 61% versus 28%, and half of consumers suggest they would consider a virtual behavioral therapist, Wieland tells investors in a research note. Even the 65 and over population is warming up to telemedicine, says the analyst. He reiterates an Overweight rating on Teladoc (TDOC). Wieland also believes Evolent Health (EVH) and Cerner (CERN) are well positioned for this trend.
12/03/18
CANT
12/03/18
NO CHANGE
CANT
Cantor 'not too worried' about Amazon's healthcare IT initiative
Cantor Fitzgerald analyst Steven Halper is "not too worried" after Amazon (AMZN) last week confirmed plans to sell software that will mine patient medical records to reduce medical expenses. The analyst does not expect traditional electronic medical record vendors, including Allscripts (MDRX), Cerner (CERN), Computer Program and Systems (CPSI) and NextGen (NXGN) to be impacted by Amazon. It "remains to be seen whether Amazon's forays into the healthcare industry will be truly disruptive," says the analyst. He believes Amazon is likely positioning itself to benefit from pharmaceutical and medical supply sales.
CPSI Computer Programs
$27.80

0.455 (1.66%)

08/03/18
PIPR
08/03/18
NO CHANGE
Target $29
PIPR
Neutral
Computer Programs price target lowered to $29 from $32 at Piper Jaffray
Piper Jaffray analyst Sean Wieland lowered his price target on Computer Programs to $29 after its Q2 earnings miss, saying the wide margin was attributed mainly to client delays in purchasing Meaningful Use required systems. The analyst notes that the management is confident in the second half recovery given the queue of pending implementations, but still sees risks of "very high stimulus incentive eligibility requirements, less than anticipated EHR adoption despite stimulus incentives, and competition". Wieland keeps his Neutral rating on Computer Programs.
MDRX Allscripts
$12.00

0.3 (2.56%)

01/18/19
KEYB
01/18/19
UPGRADE
Target $15
KEYB
Overweight
Allscripts upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Donald Hooker upgraded Allscripts to Overweight with a $15 price target.
01/18/19
KEYB
01/18/19
UPGRADE
Target $15
KEYB
Overweight
Allscripts upgraded to Overweight from Sector Weight at KeyBanc
As previously reported, KeyBanc analyst Donald Hooker upgraded Allscripts to Overweight with a $15 price target following the company's divestiture of Netsmart. In a research note to investors, Hooker says he sees material upside in the company's share price if Allscripts can show any acceleration of growth in 2019 or 2020.
11/28/18
KEYB
11/28/18
NO CHANGE
KEYB
KeyBanc sees Amazon entry having little near-term impact on HCIT space
The announcement that Amazon.com (AMZN) is developing Software-as-a-Service analytical tools for the U.S. healthcare industry called Amazon Comprehend Medical will likely bring a "lot of noise, but little real, near-term financial impact" to the publicly traded Healthcare Technology and Services space, KeyBanc analyst Donald Hooker tells investors in a research note. He believes companies potentially most relevant to Amazon's announcement include Allscripts Healthcare Solutions (MDRX), Cerner (CERN), Evolent Health (EVH), Inovalon Holdings (INOV), IQVIA Holdings (IQV), Medidata Solutions (MDSO), PRA Health Sciences (PRAH), Premier (PINC), and Teladoc Health (TDOC). Hooker argues that any potential success by mega-tech companies, such as Amazon, to develop useful SaaS analytical tools "could actually empower traditional HCIT and biopharma outsourcing companies." Further, he sees a number of "unique barriers" for "big data" solutions in clinical decision support and population health management.
PINC Premier
$37.10

0.55 (1.50%)

01/17/19
UBSW
01/17/19
INITIATION
Target $45
UBSW
Buy
Premier initiated with a Buy at UBS
UBS analyst Kevin Caliendo started Premier with a Buy rating and $45 price target. The analyst believes that after years of mostly talk around value based care, new government initiatives and coming pressure from payers should drive increased demand for Premier's services. He thinks Premier is one of the best ways investors can play the value based care story.
09/25/18
LEHM
09/25/18
INITIATION
Target $50
LEHM
Overweight
Premier initiated with an Overweight at Barclays
Barclays analyst Steve Valiquette started Premier with an Overweight rating and $50 price target. Despite a recent rally, the stock still trades at a "notable discount" to the company's five-year historical average, Valiquette tells investors in a research note. He expects the positive run rates from Premier's Q4 results to continue given the improving backdrop for Centers for Medicare and Medicaid Services reimbursement to the hospital industry "under Trump-appointed CMS leaders."
11/19/18
BARD
11/19/18
NO CHANGE
Target $50
BARD
Outperform
Baird sees Premier shares moving higher over next two months
Baird analyst Eric Coldwell believes while Premier's Q1 results were complex, they were solid underneath and he thinks others will come around to believing in the company. Given this view, he sees Premier shares moving higher over the next two months. The analyst said the stock is well set up technically and the fundamentals and valuation can be leaned on. Coldwell reiterated his Outperform rating and $50 price target on Premier shares.
VCRA Vocera
$30.90

0.9 (3.00%)

02/11/19
CHDN
02/11/19
DOWNGRADE
CHDN
Neutral
Vocera downgraded to Neutral from Buy at Chardan
02/08/19
WBLR
02/08/19
NO CHANGE
WBLR
Outperform
Vocera earnings weakness a buying opportunity, says William Blair
William Blair analyst Ryan Daniels says he's a buyer of Vocera Communications on weakness today, "especially if shares trade into the lower-$30 range." The stock in premarket trading is 22% to $30.99. Despite the noise created by the new device launch, the analyst feels good about management's visibility toward achieving, or exceeding, its initial 2019 targets. Vocera's bookings performance and backlog sets it up well for 2019 and any uptick in device bookings should drive upside to numbers, Daniels tells investors in a post-earnings research note. He believes management's guidance could prove to be conservative since the company prefers to see how the new SmartBadge launch impacts sales performance before being more aggressive with 2019 expectations. Daniels keeps an Outperform rating on Vocera.
02/08/19
SBSH
02/08/19
DOWNGRADE
Target $33
SBSH
Neutral
Citi sees Vocera range-bound through 2019, downgrades to Neutral
Citi analyst Stephanie Demko downgraded Vocera Communications to Neutral from Buy and lowered her price target for the shares to $33 from $46. The analyst says the company's "weak" 4Q bookings and 2019 guidance overshot her "negative catalyst watch expectations." Although Vocera's fiscal 2019 revenue guidance of 4%-10% should prove conservative, setting the company up for beat/raise potential throughout the year, the company would have to post eight points of upside at the midpoint to come in line with prior buy-side expectations, Demko tells investors in a post-earnings research note. The analyst continues to like Vocera's clinical workflow strategy but she believes the shares could be range-bound through 2019.
02/08/19
SBSH
02/08/19
DOWNGRADE
SBSH
Neutral
Vocera downgraded to Neutral from Buy at Citi
Citi analyst Stephanie Demko downgraded Vocera Communications to Neutral.

TODAY'S FREE FLY STORIES

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:03
02/22/19
02/22
07:03
02/22/19
07:03
Hot Stocks
AutoNation announces regional restructuring and cost savings plan »

AutoNation previously…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

SBAC

SBA Communications

$182.45

-0.57 (-0.31%)

07:03
02/22/19
02/22
07:03
02/22/19
07:03
Downgrade
SBA Communications rating change  »

Guggenheim downgrades SBA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:02
02/22/19
02/22
07:02
02/22/19
07:02
Hot Stocks
AutoNation names Carl Liebert as new CEO and President »

AutoNation announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

EADSY

Airbus

$0.00

(0.00%)

, BA

Boeing

$417.48

-4.13 (-0.98%)

07:02
02/22/19
02/22
07:02
02/22/19
07:02
Periodicals
Airbus pushes Indian budget carriers towards widebody operations, Reuters says »

Airbus (EADSY) has been…

EADSY

Airbus

$0.00

(0.00%)

BA

Boeing

$417.48

-4.13 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

  • 28

    May

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:01
02/22/19
02/22
07:01
02/22/19
07:01
Hot Stocks
Breaking Hot Stocks news story on AutoNation »

AutoNation announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

AN

AutoNation

$38.37

-0.76 (-1.94%)

07:00
02/22/19
02/22
07:00
02/22/19
07:00
Earnings
AutoNation reports Q4 cont ops EPS $1.02, consensus $1.15 »

Reports Q4 revenue $5.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

GSK

GlaxoSmithKline

$40.57

-0.193 (-0.47%)

, RYCEY

Rolls-Royce

$0.00

(0.00%)

06:59
02/22/19
02/22
06:59
02/22/19
06:59
Hot Stocks
SFO ends investigations into Rolls-Royce and GlaxoSmithKline »

The Director of the…

GSK

GlaxoSmithKline

$40.57

-0.193 (-0.47%)

RYCEY

Rolls-Royce

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

COT

Cott Corp.

$15.58

0.02 (0.13%)

06:58
02/22/19
02/22
06:58
02/22/19
06:58
Earnings
Breaking Earnings news story on Cott Corp. »

Cott Corp. sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 04

    Jun

  • 05

    Jun

TAHO

Tahoe Resources

$3.67

-0.12 (-3.17%)

06:58
02/22/19
02/22
06:58
02/22/19
06:58
Hot Stocks
Breaking Hot Stocks news story on Tahoe Resources »

Tahoe Resources trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$291.18

-11.33 (-3.75%)

06:57
02/22/19
02/22
06:57
02/22/19
06:57
Periodicals
Tesla 'rolls out' Model 3 in China ahead of schedule, Reuters says »

Tesla has started…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

PSO

Pearson

$11.55

-0.195 (-1.66%)

06:57
02/22/19
02/22
06:57
02/22/19
06:57
Earnings
Pearson sees FY19 adjusted EPS 56.5p-62p »

Pearson said: "2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBX

Dropbox

$25.58

0.1 (0.39%)

06:57
02/22/19
02/22
06:57
02/22/19
06:57
Upgrade
Dropbox rating change  »

Dropbox upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

PLNT

Planet Fitness

$58.26

-0.18 (-0.31%)

06:56
02/22/19
02/22
06:56
02/22/19
06:56
Upgrade
Planet Fitness rating change  »

Planet Fitness upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PSO

Pearson

$11.55

-0.195 (-1.66%)

06:55
02/22/19
02/22
06:55
02/22/19
06:55
Earnings
Pearson reports preliminary 2018 revenue down 1% in underlying terms »

Total underlying revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONE

CyrusOne

$52.44

-4.75 (-8.31%)

06:55
02/22/19
02/22
06:55
02/22/19
06:55
Downgrade
CyrusOne rating change  »

CyrusOne downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 18

    Jun

NDLS

Noodles & Company

$7.46

0.1 (1.36%)

06:54
02/22/19
02/22
06:54
02/22/19
06:54
Upgrade
Noodles & Company rating change  »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COT

Cott Corp.

$15.58

0.02 (0.13%)

06:54
02/22/19
02/22
06:54
02/22/19
06:54
Earnings
Cott Corp. reports Q4 EPS 1c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 04

    Jun

  • 05

    Jun

UTX

United Technologies

$126.33

-2.07 (-1.61%)

06:53
02/22/19
02/22
06:53
02/22/19
06:53
Initiation
United Technologies initiated  »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVPT

Travelport

$15.70

-0.01 (-0.06%)

06:51
02/22/19
02/22
06:51
02/22/19
06:51
Earnings
Travelport reports Q4 adj. EPS 31c, consensus 25c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 15

    Mar

  • 15

    Mar

ITT

ITT

$56.41

-0.25 (-0.44%)

06:51
02/22/19
02/22
06:51
02/22/19
06:51
Hot Stocks
ITT to acquire Rheinhutte Pumpen Group for approximately $91.5M in cash »

ITT announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

ROKU

Roku

$51.47

-2.16 (-4.03%)

06:50
02/22/19
02/22
06:50
02/22/19
06:50
Downgrade
Roku rating change  »

Roku downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITT

ITT

$56.41

-0.25 (-0.44%)

06:50
02/22/19
02/22
06:50
02/22/19
06:50
Hot Stocks
ITT announces new $25M share repurchase program »

The company is also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

FIT

Fitbit

$6.62

-0.03 (-0.45%)

06:50
02/22/19
02/22
06:50
02/22/19
06:50
Downgrade
Fitbit rating change  »

Fitbit downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

FSLR

First Solar

$51.91

0.23 (0.45%)

06:49
02/22/19
02/22
06:49
02/22/19
06:49
Recommendations
First Solar analyst commentary  »

First Solar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITT

ITT

$56.41

-0.25 (-0.44%)

06:49
02/22/19
02/22
06:49
02/22/19
06:49
Hot Stocks
ITT raises quarterly dividend 10% to 14.7c per share »

The ITT Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.